Artificial Intelligence | Machine Learning | Machine Perception Carlsmed | Personalizing Spine Surgery


Enterprise, Medical Device, Spine Surgery, Surgical Treatment, Spine Fusion Devices San Diego, CA, United States

Carlsmed

Artificial Intelligence | Machine Learning | Machine Perception


Carlsmed | Personalizing Spine Surgery

Carlsmed

Medical Device, Spine Surgery, Surgical Treatment, Spine Fusion Devices


San Diego, CA, United States

Carlsmed® uses patient data and digital technologies to create optimal surgical plans and personalized aprevo® spine fusion devices for each patient, giving you the power to achieve your surgical plan. Carlsmed leverages AI and predictive analytics to utilize prior outcomes data for personalizing the treatment of complex spinal deformities. Its mission is to improve outcomes and decrease the cost of healthcare for complex spine surgery and beyond. The company’s proprietary Aprevo platform makes surgical plans and devices tailored to the precise medical situation of every individual patient. This is transforming healthcare by finally giving spine surgeons the tools to obtain better results at a lower cost of treatment while helping adults regain their active lifestyles.

Carlsmed’s mission is to improve outcomes and decrease the cost of healthcare for spine surgery . The company’s aprevo® devices are designed to improve the standard of care for surgical treatment of patients with adult spinal malalignment. Carlsmed uses patient data and proprietary digital technologies to create optimal surgical plans and personalized aprevo® spine fusion devices for each patient. The Carlsmed® aprevo® devices are FDA cleared and have been granted FDA Breakthrough Designation, an industry first for any implanted device, and are commercially available in the U.S.

 
 

   Total Funding: $97.6M

   Funding Stage: Series C

   Business Stage: Scaling Up

   Market: B2B

   Company Size: 51 to 100

   Founded: 2018

Mar 2024

  • Carlsmed raised $52.5M Series C round. Total funding reached to $97.6M.

Oct 2021

  • Carlsmed Announces aprevo® Launch and NTAP Reimbursement

Jul 2021

  • Carlsmed and the International Spine Study Group Foundation Announce Long-term Partnership
 
 

Date

Round

$ Raised

Investors

03/18/2024

Series C

$52.2M

B Capital, U.S. Venture Partners

Date : 03/18/2024

Round: Series C

$ Raised: $52.2M

Investors: B Capital, U.S. Venture Partners

 

For AI/ML Startup Founders

Get introduced to VC/PE/CVC investors

For Investors at VC/PE firms

Get introduced to AI/ML Startup founders or founders at Carlsmed

 
 
 
Shariq Hussain


Shariq Hussain
Co-Chief Technology Officer

Michael Cordonnier


Michael Cordonnier
Co-Founder, Chief Executive Officer & Chairman of the Board

 
 

Carlsmed is growing. Want to work at Carlsmed? Carlsmed is hiring. Join team at Carlsmed

 
 
appengine.ai

World's Most Promising AI/ML Startups